Published in
American Chemical Society, ACS Medicinal Chemistry Letters, 4(10), p. 499-503, 2019
DOI: 10.1021/acsmedchemlett.8b00532
Links
Tools
Drug Design and Synthesis of First in Class PDZ1 Targeting NHERF1 Inhibitors as Anticancer Agents
Journal article published in 2019 by
Antonio Coluccia 
,
Giuseppe La Regina ,
Valentina Naccarato,
Marianna Nalli,
Viviana Orlando,
Stefano Biagioni,
Maria Laura De Angelis,
Marta Baiocchi ,
Candice Gautier,
Stefano Gianni ,
Fiorella Di Pastena,
Laura Di Magno,
Gianluca Canettieri,
Addolorata Maria Luce Coluccia,
Romano Silvestri
,
Giuseppe La Regina ,
Valentina Naccarato,
Marianna Nalli,
Viviana Orlando,
Stefano Biagioni,
Maria Laura De Angelis,
Marta Baiocchi ,
Candice Gautier,
Stefano Gianni ,
Fiorella Di Pastena,
Laura Di Magno,
Gianluca Canettieri,
Addolorata Maria Luce Coluccia,
Romano Silvestri
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving allowed
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Postprint:
archiving restricted
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Published version:
archiving forbidden
Data provided by 